Longevity Health Holdings, Inc.
corporate_fare Company Profile
Longevity Health Holdings, Inc. (OTC:XAGE) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 6 items for XAGE at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-11, rated 7/10. Across its 6 most recent items scored 7 or higher, the top rating is 9/10, with 5 rated 8 or above. Recent SEC coverage for XAGE spans SCHEDULE 13D, 4, 424B3, 8-K.
Recent high-impact activity:
- Micro-Cap Longevity Health Puts Itself Up for Strategic Review, Halts Bone-Repair R&D
- Longevity Health Discloses Going Concern Risk, Q1 Revenue Plunges 23%
- New CEO Takes 27.9% Stake, Invests $200K to Lead Turnaround Amidst Going Concern Warning
- CEO Invests $200K, Acquiring Over 30% of Longevity Health Holdings Amidst Going Concern Warning
- Longevity Health Holdings Discloses Going Concern Doubt, Nasdaq Delisting, and New CEO with $200K Private Placement
Short Interest & Short Volume
1.28 days to coverFINRA reported short interest of 2,958 shares in XAGE as of the October 30, 2026 settlement, unchanged from the prior period — about 1.3 days to cover at its recent average daily volume. On November 18, 2026, 49.5% of XAGE volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.